Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...

Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.

After weeks of being blocked by the Trump administration, one crucial step in the National Institutes of Health process for funding biomedical research is being largely restored, but it seems that ...

Forbes contributors publish independent expert analyses and insights. Anna Esaki-Smith is an author and covers higher education.

Cancer takes a staggering toll on American lives and families: Nearly 40 percent of people in the U.S. will be diagnosed with the disease at some point in their lives, and almost 1 in 5 Americans will ...

Researchers worldwide who are funded by the US National Institutes of Health (NIH) — the world’s biggest funder of biomedical research — are facing uncertainty about the future of their ...

Amid funding uncertainty as the Trump Administration continues to cut or end certain funding, the University of Pittsburgh will continue to allow admissions to its doctoral programs. They are ...

Several colleges and universities are pausing admissions to some graduate programs, reducing class sizes or rescinding offers to students in an effort to cut costs amid uncertainty in federal funding.

The biotechnology sector’s foundations rest on basic scientific research. Early experiments done in academic laboratories often yield the discoveries that venture investors later form drug startups ...

Four representatives of Elon Musk’s so-called Department of Government Efficiency (DOGE) task force have been installed at the National Institutes of Health, according to multiple sources.

In 1972, testicular cancer was a leading killer of young men — almost uniformly fatal. Today, it has a 90 percent survival rate. The drug responsible for this miraculous reversal, Cisplatin ...

DOHA, Feb 23 (Reuters) - Qatar's government has signed a five-year deal with AI data company Scale AI to deploy AI-powered tools and training in a push to improve government services in the Gulf ...